Search

Search Results
Results 1391 - 1400 of 1448 for chronic pain syndrome
  • Drug - 7 Oct 2020
    Consumer Medicine Information (CMI) about Fluanxol (Flupentixol decanoate) intended for persons living in Australia.
  • Health - 22 Jun 2020
    To further understand infection by SARS-CoV-2, researchers have reevaluated the pathogenesis associated with coronaviruses that have already been identified.
  • Health - 28 Apr 2020
    Epileptic seizures happen when there is a burst of neural activity that leads to a seizure. This article looks at the mechanism of epileptic seizures.
  • Drug - 16 Mar 2020
    Consumer Medicine Information (CMI) about Norinyl-1 (Mestranol and Norethisterone) intended for persons living in Australia.
  • Health - 16 Mar 2020
    Hyperglycemia is a medical condition characterized by high blood glucose levels. The condition is primarily caused by significantly lower blood insulin levels or improper functioning of insulin.
  • Drug - 27 Feb 2020
    Consumer Medicine Information (CMI) about Modavigil (Modafinil) intended for persons living in Australia.
  • Drug - 12 Feb 2020
    Consumer Medicine Information (CMI) about Thioprine 50 (azathioprine film-coated tablets) intended for persons living in Australia.
  • Drug - 13 Dec 2019
    Consumer Medicine Information (CMI) about Loette (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Drug - 12 Dec 2019
    Consumer Medicine Information (CMI) about Monofeme (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Health - 20 Aug 2019
    Fuchs heterochromic iridocyclitis is an ocular condition characterized by the presence of keratic precipitates, iris heterochromia and iris atrophy.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.